The emerging use of botulinum toxins for the treatment of neuropathic pain

Pain Medicine

Volumn 11, Issue 12, 2010, Pages 1750-1752

  Argoff, Charles ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; LIDOCAINE;

ALLODYNIA; COMPLEX REGIONAL PAIN SYNDROME TYPE I; DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; HUMAN; MYOFASCIAL PAIN; NEUROPATHIC PAIN; NONHUMAN; POSTHERPETIC NEURALGIA; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 78650085375     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00997.x     Document Type: Editorial

References (24)

1. Bennett GJ. Neuropathic pain: New insights, new interventions. Hosp Pract 1998;33:95-8.
2. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001;89:107-10.
3. Costigan M, Woolf CJ. Pain molecular mechanisms. J Pain 2000;1(suppl 3):35-44.
4. Xiao L, Mackey S, Hui H, Xong D, Zhang Q, Zhang D. Subcutaneous injection of botulinum toxin A is beneficial in postherpetic neuralgia. Pain Med 2010;11:1827-33.
5. Allen G, Galer BS, Schwartz L. Epidemiology of complex regional pain syndrome: A retrospective chart review of 134 patients. Pain 1999;80:539-44.
6. Simons DG, Travell JG, Simons LS. General overviews. In: Simons DG, Travell JG, Simons LS, eds. Travel & Simons' Myofascial Pain and Dysfunction: The Trigger Point Manual, 2nd edition. Vol. 1, Baltimore: Williams & Wilkins; 1999:11-93.
7. Hubbard DR, Berkoff GM. Myofascial trigger points show spontaneous needle EMG activity. Spine 1993;18:1803-7.
8. Ali Z, Raja SN, Wesselman U, et al. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 2000;88:161-8.
9. Argoff CE. Botulinum toxin type A treatment of myofascial pain in patients with CRPS Type 1(reflex sympathetic dystrophy): A pilot study. Poster Presentation at the World Pain Congress (IASP) Meeting, Vienna, Austria, August, 1999.
10. Jabbari B, Maher N, Difazio MP. Botulinum toxin type A improved burning pain and allodynia in two patients with spinal cord pathology. Pain Medicine 2003;4:206-10.
11. Gazerani P, Staahl C, Drewes AM, et al. The effects of Botulinum Toxin Type A on capsaicin-evoked pain, flare and secondary hyperalgesia in an experimental model of trigeminal sensitization. Pain 2006;122:315-25.
12. Park HJ, Lee Y, Lee J, et al. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain. Can J Anaesth 2006;53:470-7.
13. Freund B, Schwartz M. Subcutaneous BTX-A in the treatment of neuropathic pain: A pilot study. Presented at the 38th Interagency Botulism Research Coordinating Committee Meeting, October 17-19, 2001, Easton, MD.
14. Liu HT, Tsai SK, Kao MC, et al. Botulinum toxin A relieved neuropathic pain in a case of postherpetic neuralgia. Pain Med 2006;7:89-91.
15. Piovesan EJ, Teive HG, Kowacs PA, et al. An open-label study of botulinum toxin treatment of trigeminal neuralgia. Neurology 2005;65:1306-8.
16. Turk U, Ilhan S, Alp R, et al. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol 2005;28:161-2.
17. Allam N, Brasil-Neto JP, Brown G, et al. Injections of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia. Clin J Pain 2005;21:182-4.
18. Sycha T, Kranz G, Auff E, et al. Botulinum toxin in the treatment of rare head and neck pain syndromes: A systematic review of the literature. J Neurol 2004;251(suppl 1):119-30.
19. Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain 2002;3:21-7.
20. Voley M, Tepper SJ, Rapoport AM, et al. Botulinum toxin for the treatment of greater occipital neuralgia and trigeminal neuralgia: A case report and pathophysiological considerations. Cephalagia 2006;26:336-40.
21. Wittekindt C, Liu WC, Preuss SF, et al. Botulinum toxin A for neuropathic pain after neck dissection: A dose-finding study. Laryngoscope 2006;116:1168-71.
22. Tsai CP, Liu CY, Lin KP, et al. Efficacy of botulinum toxin in the relief of carpal tunnel syndrome: A preliminary experience. Clin Drug Invest 2006;26:511-5.
23. Yuan RY, Sheu JJ, Yu JM, et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind controlled trial. Neurology 2009;72:1473-8.
24. Kamen LB. Botulinum toxin type B (Myobloc™) for treatment of neuromuscular pain associated with brachial plexopathy. Poster presentation at the Annual Scientific Meeting of the American Pain Society, Baltimore, MD, March 2001.